| Aug 5 |
Organon Q2 Earnings Preview: Positive growth expected
|
| Jul 30 |
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
|
| Jul 30 |
Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
|
| Jul 25 |
Organon & Co. (NYSE:OGN) is largely controlled by institutional shareholders who own 79% of the company
|
| Jul 24 |
Organon (OGN) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
| Jul 9 |
Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024
|
| Jun 28 |
Do Options Traders Know Something About Organon (OGN) Stock We Don't?
|
| Jun 3 |
Organon (OGN) Just Overtook the 20-Day Moving Average
|
| May 24 |
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
|
